Adicet Bio (ACET) Research Hub

Adicet Bio (ACET) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.94 USD (-1.25%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.58, market cap 0.08B. This hub links to the full technical, earnings and options research available for ACET.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close3.94 USD (-1.25%)
52-week range3.81 USD – 9.97 USD
Trend regimeRange
14-day RSI8.9 (Oversold)
Trailing P/E-0.58
Market cap0.08B
Dividend yield0.00%
Next earnings2026-08-06

Available research for ACET

Earnings

ACET earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -0.58. Updated 2026-07-23.

Options: Covered Call

Covered Call on ACET: how it works, illustrative setup around the real 3.94 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on ACET: how it works, illustrative setup around the real 3.94 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on ACET: how it works, illustrative setup around the real 3.94 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

ACET technical analysis: range, last 3.94 USD, RSI 8.9, 52w range 3.81 USD–9.97 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is ACET in?

Adicet Bio (ACET) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is ACET in an uptrend or downtrend?

As of 2026-10-26, ACET is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is ACET's trailing P/E ratio?

ACET's trailing P/E is -0.58, with a market cap of 0.08B. See the earnings research page for full valuation detail.

When does ACET next report earnings?

ACET is next scheduled to report earnings on 2026-08-06.